NCT00262223View on ClinicalTrials.gov

Combined Treatment for Alcohol-Dependent Individuals With PTSD

PHASE2CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Stress Disorders, Post-TraumaticAlcohol AbuseSubstance-Related Disorders
Interventions
BEHAVIORAL

Seeking Safety

Seeking Safety cognitive-behavioral treatment intervention for comorbid PTSD and substance use disorders

DRUG

Sertraline

An anti-depressant medication, selective serotonin reuptake inhibitor (SSRI) type

DRUG

Pill placebo

Trial Locations (1)

10031

City College, City University of New York, New York

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00262223 - Combined Treatment for Alcohol-Dependent Individuals With PTSD | Biotech Hunter | Biotech Hunter